“Human Factors Plus” (HF+) is a natural extension of Noble’s deep understanding of the patient experience when it comes to self-administering drug therapies
Orlando, Florida, February 2, 2021 – Noble, an Aptar Pharma company and world leader in providing drug delivery training device programs for pharmaceutical companies and original equipment manufacturers, today announces the launch of “Human Factors Plus” (HF+), an expanded service to further optimize the patient self-administration experience by supporting its customers in bringing new products to market.
